During the past decade, Centre de réadaptation de Coubert conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 5 clinical trials were completed, i.e. on average, 500% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centre de réadaptation de Coubert" are "Nervous System Disorders" (2 trials), "Amputation of Hip and Thigh, Level Unspecified" (1 trials), "Leg Spasticity" (1 trials), "Post-stroke Spasticity" (1 trials) and "Spasticity Post-Traumatic Brain Injury" (1 trials). Many other conditions were trialed in "Centre de réadaptation de Coubert" in a lesser frequency.

Most popular intervention types in "Centre de réadaptation de Coubert" are "Biological" (4 trials), "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Botulinum toxin type A" (4 trials), "Placebo" (2 trials), "3C60-NMPK" (1 trials) and "NMPK-3C60" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre de réadaptation de Coubert" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Centre de réadaptation de Coubert". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Centre de réadaptation de Coubert, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre de réadaptation de Coubert, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".